{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:03:17Z","timestamp":1777579397473,"version":"3.51.4"},"reference-count":12,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2013,5,24]],"date-time":"2013-05-24T00:00:00Z","timestamp":1369353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Ophthalmology"],"published-print":{"date-parts":[[2014,1]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To evaluate the efficacy, safety, refractive predictability, and complications 12 months following the implantation of a foldable toric phakic intraocular lens (PIOL) for the correction of myopic astigmatism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Uncorrected visual acuity (UCVA) and best-corrected distance visual acuity (CDVA), subjective and objective manifest refraction, endothelial cell count (ECC), intraocular pressure, biomicroscopy findings, and patient-reported symptoms were the main parameters recorded pre and post the implantation of an Artiflex toric PIOL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twenty-eight eyes of 19 patients with preoperative myopia ranging from -1.00 D to -12.00 D and with astigmatism ranging from -1.00 D to -5.50 D had the Artiflex toric PIOL inserted to correct refractive error. Postoperatively, all eyes had UCVA of at least 6\/12, 94% of at least 6\/9, and 58% of at least 6\/6. The CDVA improved in 38% of eyes and vision deteriorated by one line in one eye. Postoperative mean refractive spherical equivalent was -0.25 D (range -1.25 D to 0.00 D) with mean astigmatism being -0.60 D (range -1.50 D to 0.00 D). The ECC decreased by a mean of 6.17% (SD 5.63%) at 12 months when compared with the preoperative baseline.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The Artiflex toric PIOL is an efficacious, predictable, and safe method of treating moderate to high refractive error with astigmatism.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5301\/ejo.5000298","type":"journal-article","created":{"date-parts":[[2013,7,5]],"date-time":"2013-07-05T06:11:45Z","timestamp":1373004705000},"page":"10-13","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":8,"title":["Twelve-Month Follow-up of the Artiflex Toric Phakic Intraocular Lens"],"prefix":"10.1177","volume":"24","author":[{"given":"Marc B.","family":"Guerin","sequence":"first","affiliation":[{"name":"Laser Suite, Mater Private Hospital, Dublin - Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxwell P.","family":"Treacy","sequence":"additional","affiliation":[{"name":"Mater Misericordiae University Hospital, Dublin - Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"O'Keeffe","sequence":"additional","affiliation":[{"name":"Laser Suite, Mater Private Hospital, Dublin - Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2013,5,24]]},"reference":[{"key":"bibr1-ejo.5000298","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)71745-3"},{"key":"bibr2-ejo.5000298","doi-asserted-by":"publisher","DOI":"10.1016\/S0886-3350(00)00545-9"},{"key":"bibr3-ejo.5000298","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2007.08.039"},{"key":"bibr4-ejo.5000298","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(03)00405-6"},{"key":"bibr5-ejo.5000298","doi-asserted-by":"publisher","DOI":"10.3928\/1081-597X-20050301-05"},{"key":"bibr6-ejo.5000298","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(02)01170-3"},{"key":"bibr7-ejo.5000298","doi-asserted-by":"publisher","DOI":"10.1016\/S0886-3350(00)00545-9"},{"key":"bibr8-ejo.5000298","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2007.01.037"},{"key":"bibr9-ejo.5000298","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2006.01.088"},{"key":"bibr10-ejo.5000298","doi-asserted-by":"publisher","DOI":"10.1159\/000299179"},{"key":"bibr11-ejo.5000298","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2010.10.007"},{"key":"bibr12-ejo.5000298","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2008.12.059"}],"container-title":["European Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.5301\/ejo.5000298","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.5301\/ejo.5000298","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.5301\/ejo.5000298","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T19:37:27Z","timestamp":1777405047000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.5301\/ejo.5000298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,24]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["10.5301\/ejo.5000298"],"URL":"https:\/\/doi.org\/10.5301\/ejo.5000298","relation":{},"ISSN":["1120-6721","1724-6016"],"issn-type":[{"value":"1120-6721","type":"print"},{"value":"1724-6016","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,24]]}}}